MIAMISBURG, Ohio--(BUSINESS WIRE)--Riverain Technologies is excited to announce their growth and growing commitment to the Dayton community.
Riverain Technologies – founded in 2004 as Riverain Medical – a pioneer in artificial intelligence (AI) applications for chest imaging. This innovative, cutting edge company continues to grow in Miamisburg and recently upgraded their facilities to accommodate their larger team, their visiting customers and their future aspirations. Fueling this growth is acceleration of interest in their products, including applications designed to improve early lung cancer detection, as well as other applications for detection of disease in chest X-rays and chest CTs.
Riverain CEO Steve Worrell, who joined the company since 2007 as VP of Research took the helm in 2013, shared his excitement for the company’s future. “We are on a mission to save lives through the early detection, diagnosis, and management of lung disease. We know our channel partners and healthcare providers are finding our tools increasingly critical in practice, and we can’t wait to keep bringing more value to chest imaging by doubling down on lung health and cardio-vascular diseases in the chest. As we do that, we intend to keep growing and building both our team and our tools to improve patient outcomes.”
In January, the entire team will celebrate their busy and successful 2021, kick off 2022 and inaugurate the office. “We’ve doubled over last year,” said CFO Thomas Maloney, who also led the team’s new space transition. “We have doubled our space, our team size, our partners, and grown our revenues by more than fifty percent. This team is excited to hit the ground running in 2022 – and intends to launch multiple new products in the coming year.”
